$HUMA
Humacyte, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$0.449
▼-4.95%-$0.023
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateHumacyte, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is HUMA down today? It is at $0.449 (-4.95%), and our scanner flagged it 77 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment HUMA spikes, and full due diligence on HUMA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $HUMA 77 times in the last 30 days. Create a free account to track $HUMA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on HUMA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for HUMA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Jones Keith Anthony Director | Bought (open market) | +10K | added 25% | 50K | $6K at $0.560 | Sep 14, 26 |
Jones Keith Anthony Director | Bought (open market) | +10K | added 33% | 40K | $7K at $0.690 | Aug 20, 26 |
Jones Keith Anthony Director | Bought (open market) | +30K 0.01% of company | n/a | 30K | $18K at $0.590 | Aug 17, 26 |
Sebelius Kathleen Director | Bought (open market) | +57K 0.02% of company | added 62% | 148K | $50K at $0.880 | May 19, 26 |
Parikh Shamik J Officer | Sold (automatic/other) | -46K 0.02% of company | sold 14% | 273K | $41K at $0.900 | May 18, 26 |
Sander Dale A. Officer | Sold (automatic/other) | -46K 0.02% of company | sold 15% | 267K | $41K at $0.900 | May 18, 26 |
Constantino Michael T. Director | Bought (open market) | +11K | added 33% | 44K | $10K at $0.890 | May 18, 26 |
Parikh Shamik J Officer | Acquired (grant/award) | +311K 0.1% of company | added 100% | 319K | n/a | Nov 16, 25 |
Sander Dale A. Officer | Acquired (grant/award) | +311K 0.1% of company | added 100% | 313K | n/a | Nov 16, 25 |
Niklason Laura E Officer | Sold (automatic/other) | -592K 0.2% of company | sold 34% | 1.15M | $935K at $1.58 | Aug 20, 25 |
Dougan Brady W Director | Sold (automatic/other) | -592K 0.2% of company | sold 30% | 1.39M | $935K at $1.58 | Aug 20, 25 |
Niklason Laura E Officer | Sold (automatic/other) | -1.10M 0.4% of company | sold 65% | 592K | $1.8M at $1.63 | Aug 19, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on HUMA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for HUMA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
HUMA last traded at $0.449, down 4.95% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Humacyte, Inc. Common Stock (HUMA) is next expected to report earnings on Wednesday, November 11, 2026, about 33 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The HUMA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged HUMA 77 times in the last 30 days.
HUMA (Humacyte, Inc. Common Stock) trades on XNAS, with a market cap of about $124M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge HUMA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$HUMA discussion
Sign in to ask a question or join the discussion.